Evidence map›Paper›PMID 27792139›Full record

ArticleGenes2016

Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma.

Gary Lam, Rena R Xian, Yingying Li, Kathleen H Burns, Karen L Beemon

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. TERT-Regulation and Roles in Cancer Formation.Frontiers in immunology · 2020
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gary LamDepartment of Biology, Johns Hopkins University, Baltimore, MD 21210, USA. glam5@jhu.edu.
Rena R XianDepartment of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD 212105, USA. RXian@mednet.ucla.edu.
Yingying LiDepartment of Biology, Johns Hopkins University, Baltimore, MD 21210, USA. yli9@jhmi.edu.
Kathleen H BurnsDepartment of Pathology, Johns Hopkins Medical Institutes, Baltimore, MD 212105, USA. kburns@jhmi.edu.
Karen L BeemonDepartment of Biology, Johns Hopkins University, Baltimore, MD 21210, USA. klb@jhu.edu.
Johns Hopkins University · US

Funding

CELLULAR AND MOLECULAR BIOLOGYT32GM007231 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI VAN DOREN, MARK B · 1985 to 2020
$18.4M
Oncogenes and oncogenic microRNAs in chicken tumorsR01CA124596 · NCI · JOHNS HOPKINS UNIVERSITY · PI BEEMON, KAREN L. · 2008 to 2012
$1.7M
NCI NIH HHS R01 CA124596NIGMS NIH HHS T32 GM007231
6 · The paper itself

Abstract

Non-Hodgkin lymphomas (NHL) are a heterogeneous group of immune cell neoplasms that comprise molecularly distinct lymphoma subtypes. Recent work has identified high frequency promoter point mutations in the telomerase reverse transcriptase (

Indexed as

non-Hodgkin lymphomaTelomeraseTERT promoter

Identifiers

PMID27792139
PMCPMC5126779
OpenAlexW2537230267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.